Clene CLNN
NASDAQ CLNN
$3.88 +0.12 (+3.19%)
At close: Oct 22, 2026 · 4:00 PM EDT

Clene (CLNN) Current Deferred Revenue (2020 - 2021)

Updated

Clene (CLNN) reported Current Deferred Revenue of $112,000 for Q3 2021, unchanged from the prior quarter.

Analysis

Clene (CLNN) Current Deferred Revenue (2020 - 2021) Analysis & Trends

Dating back to Q4 2020, Clene's Current Deferred Revenue record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q3 2021 came in at $112,000 (Q2 2021), $112,000 (Q1 2021) and $112,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Clene 47.43 Mn 17.36 Mn 54,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 112,000.00
Jun 30, 2021 112,000.00
Mar 31, 2021 112,000.00
Dec 31, 2020 112,000.00
API Access

Clene Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CLNN&period=max&api_key=YOUR_API_KEY